QNB Corp. Announces $42-Per-Share Public Offering, Raising ≈$48.3M

What Happened QNB Corp. (with its banking subsidiary QNB Bank) entered an underwriting agreement on August 19, 2026 with Brean Capital, LLC and Performance Trust Capital Partners, LLC to sell 1,071,428 firm shares of common stock at $42.00 per share. The underwriters had a 30-day option for an additional 160,714 shares, which they exercised on August 20, 2026, bringing the total Shares to 1,232,142. After underwriting discounts, commissions and estimated offering expenses, QNB expects net proceeds of approximately $48.3 million. The offering was registered under the company’s Form S-3 shelf (declared effective Aug. 14, 2026) and the common stock began trading on the Nasdaq Capital Market on Aug. 20, 2026 under the ticker “QNBC.” The offering is expected to close on or about Aug. 21, 2026, subject to customary closing conditions.

Key Details

• Offering price: $42.00 per share; Firm Shares: 1,071,428; Option Shares exercised: 160,714; Total Shares: 1,232,142.
• Expected net proceeds: approximately $48.3 million (after underwriting discounts/commissions and expenses).
• Underwriters: Brean Capital, LLC and Performance Trust Capital Partners, LLC; registered under Form S-3 (File No. 333-298129).
• Stated uses of proceeds: balance sheet restructuring (including repositioning available-for-sale fixed income securities), partial redemption of subordinated notes, funding new loans, supporting capital ratios and continued growth.

Why It Matters The offering provides QNB with fresh capital that management plans to use to strengthen the balance sheet, manage debt, and support lending and growth initiatives—actions that can affect the company’s liquidity, capital ratios and future income. Issuing up to 1,232,142 new shares increases the company’s outstanding share count and therefore may dilute existing shareholders’ percentage ownership. Investors should note the company’s forward-looking statements and review QNB’s risk disclosures in its Form 10-K and subsequent filings for factors that could affect outcomes.